Page last updated: 2024-12-05

4-chloromercuribenzenesulfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Chloromercuribenzenesulfonate: A cytotoxic sulfhydryl reagent that inhibits several subcellular metabolic systems and is used as a tool in cellular physiology. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11136
CHEBI ID33206
SCHEMBL ID131850
MeSH IDM0004172

Synonyms (20)

Synonym
gtpl1773
para-chloromercuriphenylsulfonate
p-chloromercuribenzenesulfonic acid
chloro(4-sulfophenyl)mercury
CHEBI:33206 ,
4-chloromercuribenzenesulfonic acid
554-77-8
pcmbs
4-chloromercuribenzenesulfonate
mercury, chloro(4-sulfophenyl)-
chloromercuriphenylsulfonate
pcmps
ai3-51823
L024007
chloro-(4-sulfophenyl)mercury
unii-5yin07w42h
SCHEMBL131850
FT-0696917
DTXSID60203954
Q27088254

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Of all tested reagents, organic mercury compounds arose as the most toxic reagents."( Hepatotoxic effects of SH-reagents in human and rat hepatocyte cultures and in situ perfused rat livers.
Boot, JH, 1996
)
0.29
" Glimepiride also protected cortical and hippocampal neurones against the toxic effects of the prion-derived peptide PrP82-146."( Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.
Bate, C; Diomede, L; Salmona, M; Tayebi, M; Williams, A, 2009
)
0.35

Dosage Studied

ExcerptRelevanceReference
" These advantages are: the composition of fluids supplying the preparation is under control; the oxygen supply to the cord is no longer dependent on the cardiovascular function, which may be impaired by the substance under study; a complete dose-response curve may be obtained from each animal; washout experiments may be performed; the action of substances can be studied in the presence of extreme concentrations of drugs, ions, etc."( The in situ perfused spinal cord of the rat. Applicability of drugs and chemicals, sodium-lithium exchange, and calcium reduction to functional intact central nervous system tissue.
Deutschmann, W; Wellhöner, HH, 1986
)
0.27
" PCMBS inhibited F uptake by up to 83% in a dose-response manner."( pH-dependent fluoride transport in intestinal brush border membrane vesicles.
Ganapathy, V; He, H; Isales, CM; Whitford, GM, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
arylmercury compound
arenesulfonic acidOrganic derivatives of sulfonic acid in which the sulfo group is linked directly to carbon of an aryl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1346320Human P2Y12 receptor (P2Y receptors)2003Seminars in vascular medicine, May, Volume: 3, Issue:2
P2Y12, a new platelet ADP receptor, target of clopidogrel.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (606)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990298 (49.17)18.7374
1990's194 (32.01)18.2507
2000's98 (16.17)29.6817
2010's15 (2.48)24.3611
2020's1 (0.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 7.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index7.66 (24.57)
Research Supply Index6.43 (2.92)
Research Growth Index4.09 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (7.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (1.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other610 (98.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]